Schedule 13G ownership disclosure
Edgewise Therapeutics Inc
Security class unavailable · CUSIP: 28036F105
Event date: 2024-01-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.6400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-24-000117
- Form type
- SC 13G
- Filer
- Edgewise Therapeutics, Inc.
- CIK
- CIK 1710072
- Filed
- Feb 01, 2024
- Reporting period
- Jan 23, 2024
- Description
- Schedule 13G beneficial ownership